Abaxis, a manufacturer of point-of-care blood analysis systems, has released a new Piccolo reagent disc panel - BioChemistry Panel Plus, the new reagent disc used by healthcare professionals, in conjunction with the Piccolo Xpress point-of-care analyzer.

The new BioChemistry Panel Plus contains the C-Reactive Protein (CRP) assay that received 510(k) clearance in late January 2010 and also includes test configuration like ALB, ALP, ALT, AMY, AST, BUN, Ca, CRE, GGT, GLU, TP, UA, which encompasses a broad spectrum of internal organ diagnostics including liver, kidney, pancreas and metabolic functions.

The BioChemistry Panel Plus is likely to be useful for practices that are interested in the detection, monitoring and treatment of diseases with inflammation or infection disorders.

The new panel may also have broad applications in the European and Asia Pacific markets, where CRP is widely used as a standard test in general health screenings and as part of routine clinical practice.

Abaxis chairman and CEO Clint Severso said that the addition of the new BioChemistry Panel Plus is a testament in medical diagnostics.

“We look forward to continuing to raise the bar on diagnostic technologies that allow physicians to better care for their patients, improve the efficiencies of our practices and reduce the overall cost of healthcare, while increasing individual practice profitability,” Severso said.